Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Classical hematology 1

Conditions

Cancer Treatment Induced Thrombocytopenia 1

Interventions

avatrombopag 5iron isomaltoside 1000 4hetrombopag 3ferric carboxymaltose 3Cytarabine 3eltrombopag 2Rivaroxaban 2Radiotherapy 2Meropenem 2Idarubicin 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Erythropoietin 2Cyclophosphamide 2Azacitidine 2thymoglobulin 1stinging nettle lectin 1romiplostim 1raltitrexed 1peppermint oil 1pegfilgrastim 1oprelvekin 1fludarabine phosphate 1fludarabine 1ferrous succinate 1ferrous fumarate 1ferric derisomaltose 1epoetin beta 1cc-486 1Vitamin B 12 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Thrombopoietin × Classical hematology × Clear all
NCT05411705 2024-03-01

Circular

The First Affiliated Hospital of Dalian Medical University

Phase 4 Unknown
165 enrolled
Classical hematology

Cancer Treatment Induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡